09:21 AM EST, 12/03/2024 (MT Newswires) -- Haemonetics ( HAE ) said Tuesday it had agreed to sell its whole blood assets to GVS, an Italy-based manufacturer of filter solutions for the healthcare and life sciences sectors.

The transaction is valued at up to $67.1 million, including an upfront payment of $44.6 million and contingent earn-outs of up to $22.5 million over the next four years, the company said.

Haemonetics ( HAE ) said the sale includes its complete portfolio of proprietary whole blood collection, processing and filtration solutions, as well as its manufacturing facility in Covina, California, and related equipment at its Tijuana, Mexico facility.

The deal is expected to close in Q1 2025.

Haemonetics' ( HAE ) shares were 1% higher in premarket trading.